CancerTYPE ID^®

Helping your doctor diagnose your cancer

Cancer may be found at a location in your body that is not the original or “primary” site of the cancer due to cancer cells’ ability to spread from one place to another (cancer that has spread to multiple locations is called a metastatic cancer). Different types of cancer exhibit unique behaviors and therefore respond differently to specific therapies. A treatment plan tailored to your exact type of cancer can lead to significant improvement in your response. Knowledge of the primary tumor site is fundamental to guiding and optimizing treatment selection for patients.¹

CancerTYPE ID is a standardized, objective molecular test based on the differential expression of 92 genes that classifies tumors by matching the gene expression pattern of a patient’s tumor tissue to a database of known tumor types and histological subtypes. CancerTYPE ID provides molecular data that a physician may use, in conjunction with other clinical and diagnostic procedures, to help identify the site of origin and histological subtype of tumors.

References:
1. National Cancer Institute Cancer Information Summaries: Adult Treatment. http://www.cancer.gov/cancertopics/pdq/adulttreatment

CancerTYPE ID Indications for Use and Limitations
CancerTYPE ID is indicated for use in tumor specimens from patients diagnosed with malignant disease and intended to aid in the classification of the tissue of origin and tumor subtype in conjunction with standard clinical and pathological assessment by a qualified physician. CancerTYPE ID is not intended to predict patient survival benefit, treatment efficacy or to distinguish between benign versus malignant lesions. Tumor types not included in the CancerTYPE ID reference database may exhibit RNA expression patterns that are similar to RNA expression patterns within the reference database.